-
Je něco špatně v tomto záznamu ?
Preassembly of specific Gβγ subunits at GABAB receptors through auxiliary KCTD proteins accelerates channel gating
T. Fritzius, R. Tureček, D. Fernandez-Fernandez, S. Isogai, PD. Rem, M. Kralikova, M. Gassmann, B. Bettler
Jazyk angličtina Země Anglie, Velká Británie
Typ dokumentu časopisecké články
- MeSH
- draslíkové kanály metabolismus genetika MeSH
- gating iontového kanálu * fyziologie MeSH
- HEK293 buňky MeSH
- lidé MeSH
- proteiny vázající GTP - beta-podjednotky * metabolismus genetika MeSH
- proteiny vázající GTP - gama-podjednotky * metabolismus genetika MeSH
- receptory GABA-B * metabolismus genetika MeSH
- Xenopus laevis MeSH
- zvířata MeSH
- Check Tag
- lidé MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
GABAB receptors (GBRs) are G protein-coupled receptors for GABA, the main inhibitory neurotransmitter in the brain. GBRs regulate fast synaptic transmission by gating Ca2+ and K+ channels via the Gβγ subunits of the activated G protein. It has been demonstrated that auxiliary GBR subunits, the KCTD proteins, shorten onset and rise time and increase desensitization of receptor-induced K+ currents. KCTD proteins increase desensitization of K+ currents by scavenging Gβγ from the channel, yet the mechanism responsible for the rapid activation of K+ currents has remained elusive. In this study, we demonstrate that KCTD proteins preassemble Gβγ at GBRs. The preassembly obviates the need for diffusion-limited G protein recruitment to the receptor, thereby accelerating G protein activation and, as a result, K+ channel activation. Preassembly of Gβγ at the receptor relies on the interaction of KCTD proteins with a loop protruding from the seven-bladed propeller of Gβ subunits. The binding site is shared between Gβ1 and Gβ2, limiting the interaction of KCTD proteins to these particular Gβ isoforms. Substituting residues in the KCTD binding site of Gβ1 with those from Gβ3 hinders the preassembly of Gβγ with GBRs, delays onset and prolongs rise time of receptor-activated K+ currents. The KCTD-Gβ interface, therefore, represents a target for pharmacological modulation of channel gating by GBRs.
Department of Auditory Neuroscience Institute of Experimental Medicine CAS Prague Czech Republic
Department of Biomedicine University of Basel Basel Switzerland
Microbial Downstream Process Development Lonza AG Visp Switzerland
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc24018826
- 003
- CZ-PrNML
- 005
- 20241024111321.0
- 007
- ta
- 008
- 241015e20240328enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.bcp.2024.116176 $2 doi
- 035 __
- $a (PubMed)38555036
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Fritzius, Thorsten $u Department of Biomedicine, University of Basel, Basel, Switzerland
- 245 10
- $a Preassembly of specific Gβγ subunits at GABAB receptors through auxiliary KCTD proteins accelerates channel gating / $c T. Fritzius, R. Tureček, D. Fernandez-Fernandez, S. Isogai, PD. Rem, M. Kralikova, M. Gassmann, B. Bettler
- 520 9_
- $a GABAB receptors (GBRs) are G protein-coupled receptors for GABA, the main inhibitory neurotransmitter in the brain. GBRs regulate fast synaptic transmission by gating Ca2+ and K+ channels via the Gβγ subunits of the activated G protein. It has been demonstrated that auxiliary GBR subunits, the KCTD proteins, shorten onset and rise time and increase desensitization of receptor-induced K+ currents. KCTD proteins increase desensitization of K+ currents by scavenging Gβγ from the channel, yet the mechanism responsible for the rapid activation of K+ currents has remained elusive. In this study, we demonstrate that KCTD proteins preassemble Gβγ at GBRs. The preassembly obviates the need for diffusion-limited G protein recruitment to the receptor, thereby accelerating G protein activation and, as a result, K+ channel activation. Preassembly of Gβγ at the receptor relies on the interaction of KCTD proteins with a loop protruding from the seven-bladed propeller of Gβ subunits. The binding site is shared between Gβ1 and Gβ2, limiting the interaction of KCTD proteins to these particular Gβ isoforms. Substituting residues in the KCTD binding site of Gβ1 with those from Gβ3 hinders the preassembly of Gβγ with GBRs, delays onset and prolongs rise time of receptor-activated K+ currents. The KCTD-Gβ interface, therefore, represents a target for pharmacological modulation of channel gating by GBRs.
- 650 12
- $a proteiny vázající GTP - beta-podjednotky $x metabolismus $x genetika $7 D044387
- 650 12
- $a receptory GABA-B $x metabolismus $x genetika $7 D018080
- 650 12
- $a proteiny vázající GTP - gama-podjednotky $x metabolismus $x genetika $7 D044388
- 650 12
- $a gating iontového kanálu $x fyziologie $7 D015640
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a HEK293 buňky $7 D057809
- 650 _2
- $a Xenopus laevis $7 D014982
- 650 _2
- $a draslíkové kanály $x metabolismus $x genetika $7 D015221
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Tureček, Rostislav $u Department of Biomedicine, University of Basel, Basel, Switzerland; Department of Auditory Neuroscience, Institute of Experimental Medicine CAS, Prague, Czech Republic
- 700 1_
- $a Fernandez-Fernandez, Diego $u Department of Biomedicine, University of Basel, Basel, Switzerland
- 700 1_
- $a Isogai, Shin $u Microbial Downstream Process Development, Lonza AG, Visp, Switzerland
- 700 1_
- $a Rem, Pascal D $u Department of Biomedicine, University of Basel, Basel, Switzerland
- 700 1_
- $a Kralikova, Michaela $u Department of Auditory Neuroscience, Institute of Experimental Medicine CAS, Prague, Czech Republic
- 700 1_
- $a Gassmann, Martin $u Department of Biomedicine, University of Basel, Basel, Switzerland
- 700 1_
- $a Bettler, Bernhard $u Department of Biomedicine, University of Basel, Basel, Switzerland. Electronic address: bernhard.bettler@unibas.ch
- 773 0_
- $w MED00000704 $t Biochemical pharmacology $x 1873-2968 $g Roč. 228 (20240328), s. 116176
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/38555036 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20241015 $b ABA008
- 991 __
- $a 20241024111315 $b ABA008
- 999 __
- $a ok $b bmc $g 2201594 $s 1230799
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2024 $b 228 $c - $d 116176 $e 20240328 $i 1873-2968 $m Biochemical pharmacology $n Biochem Pharmacol $x MED00000704
- LZP __
- $a Pubmed-20241015